Program

  • Please find below the latest version of the program agenda, including accepted oral and poster presentations. You can also download a copy of the program HERE.
  • Missed the 2nd edition? You can view the presentations and the videos on the Infectious Diseases Online.

Agenda

Last updated: 2017-10-06

Thursday, October 19, 2017

Key note
Chair: Alan Landay 
09:30hBrain-Gut-Microbiota interactions and intestinal health
Wendy Henderson, NINR, NIH, DHHS
 
Session 1: Pathogenesis
Chairs: Cara Wilson & Stacy Carrington-Lawrence
10:30hMining adaptive immunity to identify disease-promoting microbiota members in HIV
Ivan Vujkovic-Cvijin, National Institutes of Health, Mucosal Immunology Section, USA
11:00hMicrobial colonization of the gut and brain development in infancy
Rebecca Knickmeyer, UNC School of Medicine, UNC-Chapel Hill, USA
11:30hDifferential responses of colonic ILCs to gut commensal bacteria altered during HIV infection (Abstract #: O_01)
Moriah Castleman, USA
11:45hMicrobial dysbiosis does not alter immune activation or disease progression in SIV-infected rhesus macaques (Abstract #: O_02)
Alexandra Ortiz, USA
12:00hDiscussion & Session Evaluation
 
12:15hGroup Photo & Lunch Break
 
Session 2: Transmission & Prevention
Chairs: Laurel Lagenaur & Piotr Nowak
13:15hMicrobe: drug interactions and the impact on HIV infection and pathogenesis 
Nichole Klatt, University of Washington, USA
13:45hCervicovaginal microbial dynamics and its impact on HIV acquisition risk
Douglas Kwon, Ragon Institute of MGH, MIT and Harvard, USA
14:15Vaginal lactic acid inhibits production of pro-inflammatory mediators from human cervicovaginal epithelial cells associated with HIV acquisition (Abstract #: O_03)
Gilda Tachedjian, Australia
14:30Discussion & Session Evaluation
14:45Break & Poster Viewing (Abstract #: O_01 - O_04, P_01 - P_08) 
 
Session 3: GI Tract and Diet
Chairs: Nichole Klatt & Satya Dandekar
15:30h

Detrimental impact of a high fat diet on the natural history of SIV infection in non-human
Ivona Pandrea, University of Pittsburgh, USA

16:00h

Milk - guiding the infant microbiome 
Bruce German, University of California, Davis, USA

16:30hUnderstanding complexities of gut microbiome dysbiosis in HIV infected populations using a large cohort (Abstract #: O_04)
Abigail Armstrong, USA
16:45hPlasma tryptophan-kynurenine metabolites are altered with gut microbiota dysbiosis in HIV infection and associated with progression of carotid artery atherosclerosis (Abstract #: O_09)
Qibin Qi, USA
17:00hDiscussion & Session Evaluation
 
17:15Adjourn
 

Friday, October 20, 2017

Session 4: Comorbidities
Chairs: Alan Landay & Ronald Collman 
09:00hInflammatory bowel disease (IBD) and colon cancer and microbiome
William DePaolo, University of Washington, USA
09:30hMicrobial metabolites in HIV pathogenesis and comorbidities
Dana Gabuzda, Harvard Medical School, USA
10:00hComposite analysis of bacteriome and virome from HIV/HPV-coinfected pregnant women reveals proxies for intraepithelial lesions and immunodeficiency status (Abstract #: O_05)
Marcelo Soares, Brazil
10:15hDiscussion & Session Evaluation
10:30hBreak & Poster Viewing (Abstract #: O_05 - O_09, P_10 - P_16)
 
Session 5: Microbiome & Vaccines
Chairs: Que Dang & Angela Malaspina
11:30h

Aging, the microbiome and vaccine responses
Daria Hazuda, Merck, USA

12:00h

Mechanisms intersecting microbiota metabolomics with gut epithelial barrier repair in HIV infection
Satya Dandekar, University of California, Davis, USA

12:30hRole of the microbiome in HIV vaccine response heterogeneity
James Kublin, Fred Hutch and University of Washington, USA
13:00hEffect of high-risk sexual behaviour on diversity of the vaginal microbiota and abundance of lactobacillus (Abstract #: O_06)
Jocelyn Wessels, Canada
13:15h Discussion & Session Evaluation
 
13:30hLunch break
 
Session 6: Metabolomics Biologic and Technical issues
Chairs: Frederic Bushman & Roger Paredes
14:30hStudying the functional microbiome in vivo in HIV by metaproteomics approaches
Adam Burgener, University of Manitoba, Canada
15:00h

Fatty acid profiles differ in HIV infection, persist despite suppressive ART, and are associated with immune activation
Nicholas Funderburg, Ohio State University College of Medicine, USA

15:30hModulation of gut microbiota by indoleamine 2,3-dioxygenase 1 inhibitor during antiretroviral suppressed SIV infection in rhesus macaques (Abstract #: O_07)
Zhang Wang, USA
15:45hThe microbial-derived short chain fatty acid butyrate directly and differentially inhibits gut T helper cell subset activation and proliferation (Abstract #: O_08)
Jon Kibbie, USA
16:00hDiscussion & Session Evaluation
 
16:30hClosing remarks by workshop chair

 Posters

Paper ref. # TitlePresentation author
P_01Management of neurocognitive impairment in HIV patientsJason Brenchley, Italy
P_02Effects of advanced HIV disease on the dormant blood microbiotaSergio Serrano-Villar, Spain
P_03A role for dysbiotic bacteria in increased gastrointestinal neutrophil lifespan in treated HIV infectionTiffany Hensley-Mcbain, USA
P_04FuMi: A novel functional microbiome tool for metaproteomic datasets identified key bacterial pathways altered with pregnancy Sarah Mutch, Canada
P_05Depot-Medroxyprogesterone Acetate (DMPA) is associated with diversity of the vaginal microbiota and an altered vaginal microenvironment Jocelyn Wessels, Canada
P_06Cloud-based microbiome, metagenomic, and pathogen analysisHsinyi Tsang, USA
P_07Isolation of translocating bacteria in progressive SIV infection of rhesus macaques Jacob Flynn, USA
P_08Innovative pilot program on the diagnosis and management modulation of the diseases caused in the oral microbiomeKishore Shetty, USA
   
P_10Epidemiology of HIV/AIDS and syphilis among high risk groups in Pakistan Usman Waheed, Pakistan
P_11Promoting and creating awareness of HIV/AIDS in the black african communities in luton, United KingdomNelson Anti, UK
P_12Mobile HIV counselling and testing outreach: a model for community based approach to increasing uptake of HCT and antiretroviral therapy services in Benue State NigeriaGreg Abiaziem, Nigeria
P_13HIV-associated microbiome differences, geography, and inflammationDavid B Gootenberg, USA
P_14Microbiome Profiles of Chronic HIV-1 Infection under HAARTJemal Ali Mahdi, Ethiopia
P_15Molecular Epidemiology of HIV/AIDS in PakistanUsman Waheed, Pakistan
P_16Fecal microbiota composition drives immune activation in HIV-infected individualsCatherine Lozupone, USA